NCT05378139 Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization
| NCT ID | NCT05378139 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Bispebjerg and Frederiksberg |
| Condition | Surgical Complication |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,095 participants |
| Start Date | 2021-02-01 |
| Primary Completion | 2025-06-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,095 participants in total. It began in 2021-02-01 with a primary completion date of 2025-06-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of this study is to test and assess the implementation and effectiveness of continuous wireless vital signs monitoring with real-time alerts on: The frequency of patients monitored with adequate data quality as adequate clinical user satisfaction in the initial versus the last part of the trial (primary outcome).
Eligibility Criteria
Inclusion Criteria: * Adult participants (≥18 years) * Patients assessed by the clinical staff as having an acute condition with risk for clinical deterioration and being either at home (with no apparent need for hospitalization), and/or in hospital OR * Patients at either at home before, in-hospital and/or after hospitalization for elective major surgery, defined as surgery lasting more than one hour under general- or regional anaesthesia Exclusion Criteria: * The participant expected not to cooperate with study procedures. * Allergy to plaster or silicone. * Having pacemaker or Implantable Cardioverter Defibrillator (ICD) device. * Inability to give informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05378139 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Surgical Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05378139 currently recruiting?
Yes, NCT05378139 is actively recruiting participants. Contact the research team at eske.kvanner.aasvang@regionh.dk for enrollment information.
Where is the NCT05378139 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT05378139 clinical trial?
NCT05378139 is sponsored by University Hospital Bispebjerg and Frederiksberg. The trial plans to enroll 3,095 participants.